"Iatrogenesis Imperfecta"- Extent and Characteristic in NICU in Israel.

Iatrogenesis in NICU Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00264563
• Other study ID #: 80/05
• Status: Completed
• Phase: Phase 1
• First received: December 12, 2005
• Last updated: June 16, 2011
• Start date: November 2005
• Est. completion date: April 2006

Study information

• Verified date: August 2005
• Source: Bnai Zion Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: Israel: Ministry of HealthUnited States: Food and Drug Administration
• Study type: Observational

Clinical Trial Summary

Iatrogenesis is inevitable in the NICUs.

Description:

In the first 3 months of the study we will document Iatrogenic events in 3 NICUs in Israel without informing the medical and nursing staff. In the second 3 months of the study we will try to draw the attention of the medical and nursing staff that we are documenting iatogenesis, and we will assess wether this intervention will decrease the events of Iatrogenesis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 750
• Est. completion date: April 2006
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A to 6 Months

Eligibility

Inclusion Criteria:All infants in NICU -

Exclusion Criteria:None

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Iatrogenesis in NICU

Intervention

Behavioral:
• Increasing the level of awareness to Iatrogenesis
Increasing the level of awareness to Iatrogenesis
• Increasing awareness .
Increasing awareness to Iatrogenesis and active daily recordings

Locations

Country	Name	City	State
Israel	Bnai Zion Medical Center	Haifa
Israel	Bnai Zion Medical Center, Rambam Medical Center, Barzilay Medical Center	Haifa ans Ashkelon

Sponsors (1)

Lead Sponsor	Collaborator
Bnai Zion Medical Center

Country where clinical trial is conducted

Israel,